REQUEST A DEMO
Total
USD $0.00
Search more companies

Aj Pharma Holding Sdn. Bhd. (Malaysia)

Main Activities: Management of Companies and Enterprises
Full name: Aj Pharma Holding Sdn. Bhd. Profile Updated: January 24, 2025
Buy our report for this company USD 19.99 Most recent financial data: 2022 Available in: English Download a sample report

Aj Pharma Holding Sdn. Bhd. is based in Malaysia. The head office is in Kuala Lumpur. It operates in the Management of Companies and Enterprises industry. The company was established on December 14, 2012. The latest financial highlights indicate a net sales revenue drop of 30.41% in 2022. Its total assets decreased by 38.55% over the same period.

Headquarters
Unit 27.1, Level 27, Menara Felda, Platinum Park, No. 11, Persiaran Klcc
Kuala Lumpur; Federal Territories; Postal Code: 50088

Contact Details: Purchase the Aj Pharma Holding Sdn. Bhd. report to view the information.

Website: http://www.ajpharmaholding.com

Basic Information
Registered Capital:
Purchase the Aj Pharma Holding Sdn. Bhd. report to view the information.
Financial Auditors:
Purchase the Aj Pharma Holding Sdn. Bhd. report to view the information.
Incorporation Date:
December 14, 2012
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
100%
Subsidiaries
Aj Research & Pharma Sdn. Bhd.
100%
Aj Biologics Sdn. Bhd.
66.67%
Company Performance
Financial values in the chart are available after Aj Pharma Holding Sdn. Bhd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency MYR. Absolute financial data is included in the purchased report.
Net interest income
-30.41%
Operating profit (EBIT)
-26.46%
Net Profit (Loss) for the Period
-26.05%
Total Assets
-38.55%
Total Equity
-17.61%
Total Assets Trend
-38.25%
Net Interest Income Trend
-28.01%
Cost to Income Ratio
-4.75%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?